Journal
JOURNAL OF HYPERTENSION
Volume 21, Issue 10, Pages 1961-1967Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00004872-200310000-00025
Keywords
blood pressure; blood pressure variability; end organ damage; hydralazine; hypertension; nitrendipine; spontaneously hypertensive rat
Categories
Ask authors/readers for more resources
Objective It has been proposed that blood pressure variability (BPV) is positively related to end-organ damage (EOD) in hypertension. The present work was designed to observe the effects of long-term treatment with nitrendipine and hydralazine on BPV and EOD in spontaneously hypertensive rats (SHR), to examine the hypothesis that lowering BPV with an antihypertensive drug is an important factor in organ protection. Design and methods Drugs were mixed in rat chow. After 4 months of drug administration, blood pressure was recorded continuously in conscious freely moving rats for 24 h. The heart, kidneys, and brain were then isolated and examined. Results It was found that nitrendipine significantly decreased blood pressure and BPV, and significantly decreased EOD score in SHR. Hydralazine decreased blood pressure, but did not lower BPV. No effect on EOD was found in hydralazine-treated rats. In control rats (n = 38), EOD score was weakly related to systolic blood pressure (r = 0.331, P < 0.05) and closely related to long-term systolic BPV (r = 0.551, P < 0.01). In nitrendipine- treated rats, EOD score was closely related to systolic BPV (r= 0.602, P < 0.01), but not to BP level (r = 0.174, P > 0.05). Conclusion BPV plays an important role in the protecting effects of nitrendipine. (C) 2003 Lippincott Williams Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available